**Core Concept**
Aerosolized ribavirin is an antiviral agent specifically indicated for severe bronchiolitis caused by respiratory syncytial virus (RSV), the most common viral cause of lower respiratory tract infection in infants.

**Why the Correct Answer is Right**
Ribavirin is the only antiviral approved for severe RSV bronchiolitis in infants. It works by inhibiting viral RNA synthesis, reducing viral replication. Aerosolized delivery targets the lower airways directly, minimizing systemic toxicity. RSV is the predominant pathogen in bronchiolitis, especially in young children under 2 years, making this the most appropriate indication.

**Why Each Wrong Option is Incorrect**
Option B: *H. influenza* – Haemophilus influenzae is a bacterial pathogen that can cause bronchitis or pneumonia, but not the primary cause of bronchiolitis. Ribavirin is not effective against bacteria.
Option C: *Pneumococcus* – Streptococcus pneumoniae causes pneumonia and otitis, not bronchiolitis. Antibiotics, not ribavirin, are used.
Option D: *Streptococcus* – This refers to streptococcal infections, which are bacterial and unrelated to bronchiolitis; ribavirin has no antibacterial activity.

**Clinical Pearl / High-Yield Fact**
RSV is the leading cause of bronchiolitis in infants; ribavirin is only recommended in severe cases due to limited efficacy and significant side effects. In most cases, supportive care is sufficient.

✓ Correct Answer: A. RSV